A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
ALX Oncology Inc.
ALX Oncology Inc.
University of Maryland, Baltimore
M.D. Anderson Cancer Center
Fox Chase Cancer Center
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Fox Chase Cancer Center
National Cancer Institute (NCI)
Northwestern University
National Institutes of Health Clinical Center (CC)
NYU Langone Health
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center